[Occupationally acquired MRSA colonization and occupational dermatological assessments (BK-No. 3101 in the German list of Occupational Diseases) : Analysis of the DGUV documentation and expert opinion on a case with work-related MRSA-triggered atopic dermatitis].

Beruflich erworbene MRSA-Besiedelung in der berufsdermatologischen Begutachtung (BK-Nr. 3101) : Auswertung der DGUV BK-Dokumentation und Gutachtenfall mit arbeitsbedingter MRSA-getriggerter atopischer Dermatitis.

Journal

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
ISSN: 1432-1173
Titre abrégé: Hautarzt
Pays: Germany
ID NLM: 0372755

Informations de publication

Date de publication:
Aug 2020
Historique:
pubmed: 5 6 2020
medline: 18 8 2020
entrez: 5 6 2020
Statut: ppublish

Résumé

Person-to-person transmitted infectious diseases can cause occupational diseases (OD). These are subsumed as BK-No. 3101 in the German list of OD which applies for individuals with a considerably higher risk for infection as a consequence of their professional activity compared to the general population. The special medical and insurance law aspects of a work-related MRSA colonization are presented using the example of an expert opinion case and an evaluation of the BK reports of suspected occupational disease (BK No. 3101) of the German Social Accident Insurance (DGUV). The BK documentation of the DGUV from 2007-2012 and the patient cohort from the Department of Dermatology, University Hospital Erlangen, presenting for expert assessment from 2007-2012 were retrospectively analysed for human-to-human transmitted infectious diseases of the skin (BK-No. 3101). Person-to-person transmission of infectious diseases of the skin is rare in the field of occupational dermatology. In the DGUV cohort, suspected BK-No. 3101cases amounted to 2.6% of all notified cases; recognized BK-No. 3101 cases accounted for 4.2% of all recognized cases, amongst which 9 were caused by MRSA. In contrast to a symptomatic infection, an asymptomatic MRSA colonization is not being recognized as BK-No. 3101. Bacterial superantigens can trigger atopic dermatitis (AD). In particular cases, occupationally acquired MRSA can elicit AD and may justify classification as an OD (BK-No. 3101). Early detection of MRSA colonization and eradication are necessary for rehabilitation. Management of skin diseases due to infectious diseases within the framework of OD is presented.

Sections du résumé

BACKGROUND BACKGROUND
Person-to-person transmitted infectious diseases can cause occupational diseases (OD). These are subsumed as BK-No. 3101 in the German list of OD which applies for individuals with a considerably higher risk for infection as a consequence of their professional activity compared to the general population.
OBJECTIVES OBJECTIVE
The special medical and insurance law aspects of a work-related MRSA colonization are presented using the example of an expert opinion case and an evaluation of the BK reports of suspected occupational disease (BK No. 3101) of the German Social Accident Insurance (DGUV).
PATIENTS AND METHODS METHODS
The BK documentation of the DGUV from 2007-2012 and the patient cohort from the Department of Dermatology, University Hospital Erlangen, presenting for expert assessment from 2007-2012 were retrospectively analysed for human-to-human transmitted infectious diseases of the skin (BK-No. 3101).
RESULTS RESULTS
Person-to-person transmission of infectious diseases of the skin is rare in the field of occupational dermatology. In the DGUV cohort, suspected BK-No. 3101cases amounted to 2.6% of all notified cases; recognized BK-No. 3101 cases accounted for 4.2% of all recognized cases, amongst which 9 were caused by MRSA. In contrast to a symptomatic infection, an asymptomatic MRSA colonization is not being recognized as BK-No. 3101. Bacterial superantigens can trigger atopic dermatitis (AD). In particular cases, occupationally acquired MRSA can elicit AD and may justify classification as an OD (BK-No. 3101).
CONCLUSIONS CONCLUSIONS
Early detection of MRSA colonization and eradication are necessary for rehabilitation. Management of skin diseases due to infectious diseases within the framework of OD is presented.

Identifiants

pubmed: 32494841
doi: 10.1007/s00105-020-04616-0
pii: 10.1007/s00105-020-04616-0
pmc: PMC7268186
doi:

Types de publication

Journal Article

Langues

ger

Sous-ensembles de citation

IM

Pagination

613-623

Références

BMC Infect Dis. 2011 May 20;11:138
pubmed: 21599908
Indian J Dermatol Venereol Leprol. 2014 May-Jun;80(3):229-34
pubmed: 24823400
J Allergy Clin Immunol Pract. 2014 Jul-Aug;2(4):396-9
pubmed: 25017526
J Dtsch Dermatol Ges. 2009 Jan;7 Suppl 1:S1-46
pubmed: 19138304
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Jun;57(6):696-732
pubmed: 24987771
Hautarzt. 2008 Aug;59(8):659-65; quiz 666
pubmed: 18636237
Chem Immunol Allergy. 2012;96:113-119
pubmed: 22433380
Lancet Infect Dis. 2008 May;8(5):289-301
pubmed: 18471774
Genome Res. 2012 May;22(5):850-9
pubmed: 22310478
Allergy. 2011 Mar;66(3):351-9
pubmed: 20831718
J Dtsch Dermatol Ges. 2015 Oct;13(10):1015-23
pubmed: 26408464
BMC Infect Dis. 2014 Jul 03;14:363
pubmed: 24996225
Med Klin Intensivmed Notfmed. 2017 Apr;112(3):186-191
pubmed: 28378152
Allergy. 2008 Jun;63(6):728-34
pubmed: 18445187
J Dtsch Dermatol Ges. 2012 Mar;10(3):186-96
pubmed: 22212172
J Occup Med Toxicol. 2013 May 27;8(1):16
pubmed: 23710905
Hautarzt. 2016 Jan;67(1):6-15
pubmed: 26016829
Allergy Asthma Immunol Res. 2019 Sep;11(5):593-603
pubmed: 31332972
Acta Derm Venereol Suppl (Stockh). 1989;144:50-4
pubmed: 2800907
Allergol Int. 2011 Mar;60(1):17-24
pubmed: 21252615
N Engl J Med. 2011 Oct 6;365(14):1315-27
pubmed: 21991953
J Clin Microbiol. 2008 Feb;46(2):456-61
pubmed: 18077648

Auteurs

Cornelia Erfurt-Berge (C)

Hautklinik Universitätsklinikum Erlangen, Erlangen, Deutschland.

Anne Schmidt (A)

Büro für Berufsdermatologie, Begutachtung und Betriebsberatung, Nürnberg, Deutschland.

Irena Angelovska (I)

Hautklinik Universitätsklinikum Erlangen, Erlangen, Deutschland.
Hautarztpraxis Wolfratshausen, Wolfratshausen, Deutschland.

Vera Mahler (V)

Hautklinik Universitätsklinikum Erlangen, Erlangen, Deutschland. vera.mahler@pei.de.
Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, 63225, Langen, Deutschland. vera.mahler@pei.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH